Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: Potential use of bone morphogenetic protein-2 for cartilage cell therapy;Réponse des chondrocytes humains à la bone morphogenetic protein-2 après leur dédifférenciation in vitro : utilisation potentielle de la bone morphogenetic protein-2 pour la thérapie cellulaire du cartilage

Pathologie Biologie

Volumn 57, Issue 4, 2009, Pages 282-289

  Salentey, V ^a,b,c   Claus, S ^a,b,c   Bougault, C ^a,b   Paumier, A ^a,b   Aubert Foucher, E ^a,b   Perrier Groult, E ^a,b   Ronziere M C ^a,b   Freyria, A M ^a,b   Galera P ^d   Beauchef, G ^d   Duterque Coquillaud, M ^e   Piperno, M ^f   Damour, O ^c   Herbage, B ^g   Mallein Gerin, F ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b University Lyon i   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e INSTITUT DE BIOLOGIE DE LILLE   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

^g Symatese Biomatériaux   (France)

Author keywords

Autologous chondrocytes implantation; Bone morphogenetic protein 2; Cartilage; Cell therapy; Type II collagen

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 2; OSTEOCALCIN; PLASTIC; PROCOLLAGEN; PROCOLLAGEN TYPE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE BIOPSY; BONE DEVELOPMENT; CARTILAGE CELL; CELL DEDIFFERENTIATION; CELL EXPANSION; CELL THERAPY; CHONDROCYTE IMPLANTATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NOSE CARTILAGE; NOSE SEPTUM RECONSTRUCTION; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 67349181301     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.04.013     Document Type: Article

References (34)

1. Le Guellec D., Mallein-Gerin F., Treilleux I., Bonaventure J., Peysson P., and Herbage D. Localization of the expression of type I, II and III collagen genes in human normal and hypochondrogenesis cartilage canals. Histochem J 26 9 (1994) 695-704
2. Bluteau G., Labourdette L., Ronziere M., Conrozier T., Mathieu P., Herbage D., et al. Type X collagen in rabbit and human meniscus. Osteoarthritis Cartilage 7 5 (1999) 498-501
3. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 14 (1994) 889-895
4. Redman S.N., Oldfield S.F., and Archer C.W. Current strategies for articular cartilage repair. Eur Cell Mater 9 (2005) 23-32 discussion 23-32
5. Peterson L., Minas T., Brittberg M., Nilsson A., Sjogren-Jansson E., and Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 374 (2000) 212-234
6. Cancedda R., Descalzi Cancedda F., and Castagnola P. Chondrocyte differentiation. Int Rev Cytol 159 (1995) 265-358
7. Stokes D.G., Liu G., Coimbra I.B., Piera-Velazquez S., Crowl R.M., and Jimenez S.A. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46 2 (2002) 404-419
8. Valcourt U., Gouttenoire J., Aubert-Foucher E., Herbage D., and Mallein-Gerin F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 545 2-3 (2003) 115-119
9. Yeh L.C., Mallein-Gerin F., and Lee J.C. Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells. J Cell Physiol 191 3 (2002) 298-309
10. Mallein-Gerin F. Sub epithelial type II collagen deposition during embryonic chick limb development. Roux Arch Dev Biol 198 (1990) 363-369
11. Lui V.C., Ng L.J., Nicholls J., Tam P.P., and Cheah K.S. Tissue-specific and differential expression of alternatively spliced alpha 1(II) collagen mRNAs in early human embryos. Dev Dyn 203 2 (1995) 198-211
12. Nah H.D., and Upholt W.B. Type II collagen mRNA containing an alternatively spliced exon predominates in the chick limb prior to chondrogenesis. J Biol Chem 266 34 (1991) 23446-23452
13. Ng L.J., Tam P.P., and Cheah K.S. Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and nonchondrogenic tissues during early mouse development. Dev Biol 159 2 (1993) 403-417
14. Ryan M.C., and Sandell L.J. Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem 265 18 (1990) 10334-10339
15. Sandell L.J., Morris N., Robbins J.R., and Goldring M.B. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol 114 6 (1991) 1307-1319
16. Sandell L.J., Nalin A.M., and Reife R.A. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn 199 2 (1994) 129-140
17. Bluteau G., Gouttenoire J., Conrozier T., Mathieu P., Vignon E., Richard M., et al. Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. Biorheology 39 1-2 (2002) 247-258
18. Valcourt U., Ronziere M.C., Winkler P., Rosen V., Herbage D., and Mallein-Gerin F. Different effects of bone morphogenetic proteins 2, 4, 12, and and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res 251 2 (1999) 264-274
19. Kolettas E., Buluwela L., Bayliss M.T., and Muir H.I. Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes. J Cell Sci 108 Pt 5 (1995) 1991-1999
20. Martin I., Jakob M., Schafer D., Dick W., Spagnoli G., and Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9 2 (2001) 112-118
21. Park Y., Sugimoto M., Watrin A., Chiquet M., and Hunziker E.B. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage 13 6 (2005) 527-536
22. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 16 2 (1997) 174-178
23. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., and de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17 4 (1997) 2336-2346
24. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275 15 (2000) 10738-10744
25. von der Mark K., Gauss V., von der Mark H., and Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267 5611 (1977) 531-532
26. Hauschka P.V., Lian J.B., Cole D.E., and Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69 3 (1989) 990-1047
27. Sailor L.Z., Hewick R.M., and Morris E.A. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J Orthop Res 14 6 (1996) 937-945
28. Stewart M.C., Saunders K.M., Burton-Wurster N., and Macleod J.N. Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res 15 1 (2000) 166-174
29. Grunder T., Gaissmaier C., Fritz J., Stoop R., Hortschansky P., Mollenhauer J., et al. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 12 7 (2004) 559-567
30. Valcourt U., Gouttenoire J., Moustakas A., Herbage D., and Mallein-Gerin F. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem 277 37 (2002) 33545-33558
31. Kim D.J., Moon S.H., Kim H., Kwon U.H., Park M.S., Han K.J., et al. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 28 24 (2003) 2679-2684
32. Lefebvre V., Li P., and de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. Embo J 17 19 (1998) 5718-5733
33. Kafienah W., Jakob M., Demarteau O., Frazer A., Barker M.D., Martin I., et al. Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng 8 5 (2002) 817-826
34. Vinatier C., Magne D., Moreau A., Gauthier O., Malard O., Vignes-Colombeix C., et al. Engineering cartilage with human nasal chondrocytes and a silanized hydroxypropyl methylcellulose hydrogel. J Biomed Mater Res A 80 1 (2007) 66-74